Purchase Order 75N95023P00450
Award Date 7/18/23
Potential Completion Date 8/1/23
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Minneapolis, MN 55413, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $23,656.84 firm fixed price purchase order to Proteinsimple, a division of Bio-Techne Corporation. The contract is to provide Lindsay Kryszak with a custom SimplePlex cartridge kit for 32 samples to support protein analysis. Performance will occur in Baltimore, Maryland over a one year period from December 2023 through December 2024. No subcontractors or set aside designations...
- The Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse awarded a $12,087 purchase order to Med Associates, Inc., doing business as Med Associates, for unspecified services or products. The contract has a one-year period of performance beginning July 7, 2023 through July 6, 2024 and utilizes a firm fixed price contracting structure. Place of performance will be Med Associates' Baltimore, Maryland location. No additional details were...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a firm fixed price purchase order valued at fourteen thousand three hundred ninety-five dollars and fifteen cents ($14,395.15) to FEI Company Materials And Stuctural Analysis Division Division. The contract period is from August 17, 2023 to January 17, 2024 and calls for delivery of CATALOG # : QUOTE#122299 / PREF TECNAI12BT / D347 / F1040254. Place of performance will be in...
- The Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse awarded a $24,978.26 firm fixed price purchase order to Neuronexus Technologies, Inc., doing business as Nuvectra, for data acquisition printed circuit boards to support scientific research. The contract has a period of performance of September 7, 2023 through September 6, 2024. Place of performance will be Nuvectra's facilities in Baltimore, Maryland. No set aside designation or...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $10,478 purchase order to Thermo Electron North America LLC for a PCI KIT TO CONDUCT DPCR EXPERIMENTS. As the prime contractor, Thermo Electron North America LLC will deliver the requested polymerase chain reaction kit and related materials from its Baltimore, Maryland location to support drug abuse research being conducted by the National Institute on Drug Abuse. The firm fixed...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $10,465 firm fixed price purchase order to Cambrex High Point, Inc. to support retesting of the GLWL-01 reference standard and project specific funding. Cambrex will perform the work in Baltimore, Maryland over a one year period from July 2023 through July 2024. The National Institute on Drug Abuse conducts important biomedical research on drug abuse and addiction to improve...
- The Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse awarded a $105,000 firm fixed price purchase order to New York Stem Cell Foundation Inc. as the prime contractor. The contract is to support the agency's research efforts and will be performed in New York, New York over a one year period from September 2023 through September 2024. No major subcontractors or set aside designations were indicated. The National Institute on Drug Abuse...
- The Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse awarded a $24,825 purchase order to Sigma-Aldrich, Inc. for contract 1107546 under contract number 23-005532. Performance will take place in Baltimore, Maryland over the course of one year beginning in September 2023. The firm fixed price contract is for the procurement of products or services to support NIH/NIDA research efforts, though details of the work were not provided....
- <p>The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a Firm Fixed Price Purchase Order contract to Aushon Biosystems, Inc., a for-profit organization, for $124,879.00. The contract has a completion date of September 29, 2018 and was awarded on September 22, 2017. The place of performance is Billerica, MA 01821, USA. This contract does not have a set-aside designation.</p>
- The U.S. Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $11,210.00 Firm Fixed Price Purchase Order to ABX Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien GMBH, a foreign-owned for-profit limited liability company. The contract, which does not have a set-aside designation, is for the delivery of custom order quantities of the SDM-8 tin precursor compound in 200 mg, 10 mg, and 5 mg vials. The place of...
The Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse awarded a $11,685 purchase order to Bio-Techne Sales Corporation of Minneapolis, Minnesota. The firm fixed price contract is to provide research and development systems in support of NIH/NIDA programs addressing substance abuse and addiction. Performance will take place in Minneapolis over a two week period concluding on August 1, 2023. No subcontractors or set aside designations were indicated.
Generated 12/17/23, 5:51 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.7k | 7/18/23 |